Blood Pressure Status Modulates the Therapeutic Response to Sodium‐Glucose Cotransporter 2 Inhibitors in Diabetic Macular Edema: A Post Hoc Subgroup Analysis of the COMET Trial

ABSTRACT Aims To evaluate the feasibility of sodium‐glucose cotransporter 2 inhibitors (SGLT2i) as a systemic adjunct for patients with diabetic macular edema (DME) and hypertension. Materials and Methods This study encompassed a post hoc analysis of the COMET Trial data, focusing on patients with D...

Descrición completa

Detalles Bibliográficos

Principais autores:	Ryoichi Ishibashi, Masaya Koshizaka, Yoko Takatsuna, Tomoaki Tatsumi, Takayuki Baba, Shuichi Yamamoto, Koutaro Yokote
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wiley 2025-12-01
Series:	Journal of Diabetes
Assuntos:	anti‐vascular endothelial growth factor injection diabetic macular edema hypertension sodium‐glucose cotransporter 2 inhibitor
Acceso en liña:	https://doi.org/10.1111/1753-0407.70184
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!